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Edited by Robert BaroukiAbstract Zerumbone (ZER), a sesquiterpene compound occur-
ring in tropical ginger Zingiber zerumbet Smith, has been
implicated as one of the promising chemopreventive agents
against colon and skin cancer. In the present study, we
investigated the phase II detoxiﬁcation enzymes induction of
ZER using a cultured rat normal liver epithelial cell line.
Exposure of RL34 cells to ZER resulted in the signiﬁcant
induction of glutathione S-transferase, while the reduced ana-
logues of ZER (a-humulene and 8-hydroxy-a-humulene) did not
show any inducing eﬀect. Therefore, the electrophilic property,
characterized by the reactivity with intracellular nucleophiles
including protein sulfhydryls as well as low molecular weight
thiols, at the 8-position a; b-unsaturated carbonyl group plays an
important role in the induction of phase II enzymes. ZER
induced nuclear localization of the transcription factor Nrf2 that
binds to antioxidant response element (ARE) of the phase II
enzyme genes, suggesting that ZER is a potential activator of the
Nrf2/ARE-dependent detoxiﬁcation pathway. This is consistent
with the observation that ZER potentiated the gene expression of
several Nrf2/ARE-dependent phase II enzyme genes, including c-
glutamylcysteine synthetase, glutathione peroxidase, and heme-
oxygenase-1. The present study also implied the antioxidant role
of this detoxiﬁcation system activation by ZER in the neutral-
ization of lipid peroxidation in hepatocytes, providing a new
insight for cancer prevention.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Zerumbone (ZER, Fig. 1A) is a sesquiterpene compound
occurring in rhizomes of Zingiber zerumbet Smith (Zingiber-
aceae), previously identiﬁed as a distinct suppressor of tumor
promoter 12-O-tetradecanoylphorbol-13-acetate (TPA)-in-
duced Epstein–Barr virus (EBV) activation in Raji cells [1]. In
some Southeast Asian countries, the rhizomes of the plant are
employed as a traditional medicine for anti-inﬂammation,
while the young shoots and inﬂorescence are used as condi-* Corresponding author. Fax: +81-52-789-5741.
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0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.07.042ments [1]. The recent study demonstrated that ZER eﬀectively
suppressed TPA-induced superoxide anion generation from
both NADPH oxidase in dimethylsulfoxide-diﬀerentiated HL-
60 human acute promyelocytic leukemia cells and xanthine
oxidase in AS52 Chinese hamster ovary cells [2]. ZER also
markedly diminished the combined lipopolysaccharide- and
interferon-c-stimulated protein expressions of inducible nitric
oxide synthase and cyclooxygenase (COX)-2, together with the
release of tumor necrosis factor-a, in RAW 264.7 mouse
macrophages. Moreover, ZER inhibited the proliferation of
human colonic adenocarcinoma cell lines in a dose-dependent
manner, while the growth of normal human dermal and colon
ﬁbroblasts was less aﬀected. Intriguingly, a-humulene (HUM,
Fig. 1A), a structural analogue lacking only the carbonyl
group in ZER, was virtually inactive in all experiments con-
ducted, indicating that the a; b-unsaturated carbonyl group in
ZER may play some pivotal roles in interactions with un-
identiﬁed target molecule(s) [2]. Subsequently, ZER was
demonstrated to inhibit both azoxymethane-induced rat ab-
errant crypt foci and phorbol ester-induced papilloma forma-
tion in mouse skin as a further indication for its eﬃcacy to
prevent colon and skin cancers [3,4]. Therefore, ZER is a
promising dietary agent that has distinguishable potentials for
use in anti-inﬂammation, chemoprevention, and chemotherapy
strategies.
Several lines of evidence indicate that phase II xenobiotic
metabolizing enzymes, such as glutathione S-transferase (GST)
and NAD(P)H:(quinone-acceptor) oxidoreductase (NQO),
play a major role in the cellular detoxiﬁcation of oxidative
damaging, genotoxic and carcinogenic chemicals [5]. It is
widely accepted that the induction of phase II enzymes results
in protection against toxicity and chemical carcinogenesis, es-
pecially during the initiation phase. GSTs are a family of sol-
uble proteins, which conjugate xenobiotics with glutathione.
Metabolites after glutathionylation are more hydrophilic and
thus biologically inactive. Therefore, they are readily excreted
in bile or urine as conjugates. This action is thus believed to be a
major mechanism for the detoxiﬁcation of reactive ultimate
carcinogens. It is now generally accepted that the GSTs are
encoded by at least eight diﬀerent gene families (including
classes alpha, mu, pi, theta, zeta, omega, sigma and kappa) of
cytosolic GSTs. Class pi GST (GSTP1-1), one of the GST
isozymes, can profoundly alter susceptibility to chemical car-
cinogenesis possibly through glutathione (GSH) conjugation
of carcinogens [6–8], including widespread environmentalation of European Biochemical Societies.
Fig. 1. Electrophilic ZER, but 8-OH-HUM, and HUM does not, in-
duces GST in RL34 cells. (A) Chemical structures of zerumbone
(ZER), 8-hydroxy-a-humulene (8-OH-HUM), and a-humulene
(HUM). (B) Eﬀect of ZER, 8-OH-HUM, and HUM on total cellular
GST activity. Cells’ post-conﬂuency was exposed to the test com-
pounds (25 lM) in the medium containing 5% fetal bovine serum for
24 h. GST activity was measured using CDNB as a substrate. Statis-
tical signiﬁcance was determined by the Student’s t test and is ex-
pressed as: *, versus control treated only with DMSO, P < 0:05.
(C) Induction-of pi-Class GST protein (GSTP1) by ZER, 8-OH-
HUM, and HUM. Cells’ post-conﬂuency were exposed to the test
compounds (25 lM) in the medium containing 5% fetal bovine serum
for 24 h. The GSTP1 level was evaluated by an immunoblot analysis.
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(ARE/EpRE; consensus sequence TGACNNNGC) or the re-
lated element, regulating both its basal and inducible expres-
sion, was mostly found in the 50-ﬂanking region of genes of the
phase II enzymes and may be recognized by a similar series of
transcriptional factors [5]. The induction of phase II xenobiotic
metabolizing enzymes has been reported to be evoked by a
variety of chemical agents, including Michael reaction accep-
tors, quinines and others, most of which are electrophiles [9].
Among them, Isothiocyanate (ITC) compounds, including
sulforaphane and benzyl ITC, are well known to induce the
phase II enzyme in rat liver and cancer chemopreventive eﬀects
in several rodent models [10]. Epidemiological studies also
demonstrated that dietary consumption of the ITC compounds
or urinary ITC level was associated with signiﬁcantly reduced
risk of several cancers [11,12]. These results implied that the
enhanced detoxiﬁcation of carcinogens by the ITC compounds
might be involved in cancer prevention in humans. Therefore,
food chemicals inducing phase II enzyme activities are antici-
pated to be highly useful in anti-carcinogenic strategies.
In the present study, we evaluated ZER as an inducer of
GSH-related phase II enzymes including GST. We also ex-
amined the structure–activity relationship study of the a; b-
unsaturated carbonyl moiety and discussed, based on the
structural factor, the chemical reactivity required for enzyme
induction. In addition, the Fe2þ-induced lipid peroxidation in
hepatocyte can be aﬀected by the detoxiﬁcation system acti-
vation by ZER.2. Materials and methods
2.1. Materials
ZER was isolated from the rhizomes of Z. zerumbet Smith as pre-
viously reported (purity >99%) [1]. HUM was purchased from TokyoKasei Kogyo, Tokyo, Japan. 8-Hydroxy-a-humulene (8-OH-HUM)
was synthesized as previously reported [1]. TPA was obtained from
Research Biochemicals International, Natick, MA. Cycloheximide
(CHX) was obtained from Sigma, St. Louis, MO. MG132 was pur-
chased from Calbiochem, Darmstadt, Germany. Anti-rat GSTP1-1
antiserum was obtained from Biotrin International, Dublin, Ireland.
Anti-Nrf2 polyclonal antibody was purchased from Santa Cruz, Santa
Cruz, CA. Anti-cytochrome P450 (CYP) 1A1/2 antiserum was ob-
tained from Daiichi Nippon Pharmacology Co., Tokyo, Japan.
Horseradish peroxidase-linked anti-rabbit IgG immunoglobulin was
purchased from Dako, Glostrup, Denmark. The protein concentration
was measured using the BCA protein assay reagent from Pierce,
Rockford, IL.
2.2. Cell cultures
RL34 cells were obtained from the Health Science Research Re-
sources Bank, Osaka, Japan [13]. The cells were grown as monolayer
cultures in Dulbecco’s modiﬁed Eagle’s medium supplemented with 5%
heat-inactivated fetal bovine serum, penicillin (100 U/ml), streptomycin
(100 lg/ml), L-glutamine (0.3 mg/ml), pyruvic acid (0.11 mg/ml) and
0.37% NaHCO3 at 37 C in an atmosphere of 95% air and 5% CO2.
2.3. Enzyme assay
GST activity was measured using l-chloro-2,4-dinitrobenzene
(CDNB) and ethacrynic acid (EA) as substrates according to the
method of Habig and Jakoby [14].
2.4. Western blot analysis
The ZER-treated and untreated cells were rinsed twice with PBS (pH
7.0) and lysed by incubation at 37 C for 10 min with a solution
containing 0.8% digitonin and 2 mM EDTA (pH 7.8). Each whole cell
lysate was then treated with Laemmli sample buﬀer for 3 min at 100 C
[15]. The samples (20 lg) were run on 12.5% SDS–PAGE slab gel. One
gel was used for staining with Coomassie brilliant blue and the other
was transblotted on a nitrocellulose membrane with a semi-dry blot-
ting cell (Trans-Blot SD, Bio-Rad), incubated with Block Ace (40 mg/
ml) for blocking, washed, and treated with the antibody.
2.5. Immunochemical detection of Nrf2 nuclear translocation
The cells treated with ZER were ﬁxed overnight in PBS containing
2% paraformaldehyde and 0.2% picric acid at 4 C. The membranes
were permeabilized by exposing the ﬁxed cells to PBS containing 0.3%
Triton X-100. The cells were then sequentially incubated in PBS so-
lutions containing blocking serum (5% normal rabbit serum) and im-
munostained with the anti-Nrf2 polyclonal antibody. The cells were
then incubated for 1 h in the presence of ﬂuorescein isothiocyanate-
labeled rabbit anti-goat (DAKO A/S, Glostrup, Denmark), rinsed with
PBS containing 0.3% Triton X-100, and covered with anti-fade solu-
tion. Images of the cellular immunoﬂuorescence were acquired using a
confocal laser microscope (Bio-Rad, Hercules, CA) with a 40 ob-
jective (488-nm excitation and 518-nm emission).
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
The RT reaction was performed with 5 lg of total RNA and an
oligo(dT) primer using the First-Strand cDNA synthesis kit (Life
Technology Inc., Rockville, MD). The reaction mixture was then
subjected to brief incubation at 65 C in order to inactivate the
enzyme. PCRs were carried out as previously reported [16]. The
following primers were used: GSTP1, (F) 50-GCAGATATC-
CAATGCCGCCGTACACCATT-30 and (R) 50-GGACTCGAGC-
TACTGTTTACCATTGCCGT-30 (25 cycles, product size 630 bp);
glutathione reductase (GR), (F) 50-GATAACCAGTGATGGG-
TTCTTT-30 and (R) 50-TTGGAGCAAAGTAGAGTGGTGA-30
(25 cycles, product size 472 bp); NQO1, (F) 50-GGCTGGTTTGA-
GAGAGTG-30 and (R) 50-GTCGGCTGGAATGGACTTG-30 (35
cycles, product size 459 bp); hemeoxygenase-1 (HO-1), (F) 50-CAG-
CACTACGTAAAGCGTCTCC-30 and (R) 50-AGTGCTGATCTG-
GGATTTTCCT-30 (25 cycles, product size 452 bp); c-glutamylcysteine
synthetase light chain (cGCSl), (F) 50-CTTGAATGAATGG-
AGTTCCCA-30 and (R) 50-TACCTGT GCCCACTGATACAGC-30
(27 cycles, product size 400 bp); c-GCS heavy chain (cGCSh), (F) 50-
CCAGTTCCTGCACATCTACCACGC-30 and (R) 50-GCAGAAAT-
CACTCCCCAGCGAC-30 (27 cycles, product size 800 bp); GAPDH,
(F) 50-CGAGATCCCTCCAAAATCAA-30 and (R) 50-AGGTCC-
ACCACTGACACGTT-30 (25 cycles, product size 345 bp).
Fig. 2. Induction of pi-Class GST protein (GSTP1) by ZER in RL34
cells. (A) Dose-dependent eﬀect of ZER (1–25 lM) on GSTP1 protein
level. Cells’ post-conﬂuency was exposed to the test compounds for 24
h. (B) Time-dependent eﬀect of ZER on GSTP1 and CYP1A1 protein
levels. Cells’ post-conﬂuency was exposed to the test compound (25
lM) for the diﬀerent periods as indicated. GSTP1 and CYP1A1 levels
were evaluated by an immunoblot analysis. 3MC; 3-methylcholan-
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The quantitation of GSH was ﬂuorometrically performed according
to the method of Hissin and Hilf [17]. Cells were lysed and extracted
with 5% metaphosphoric acid solution containing 5 mM EDTA. After
centtrifugation (10 000g, 20 min), a 1.8 ml aliquot of 0.1 M phos-
phate solution (pH 8.0) containing 5 mM EDTA and 100 ll of the o-
phthalaldehyde solution (1 mg/ml) were then added to the supernatant
(100 ll). The ﬂuorescence intensity at 420 nm was next determined with
activation at 350 nm.
2.8. Lipid peroxidation test and TEARS quantiﬁcation
Brieﬂy, to determine the inhibitory eﬀect of ZER on lipid peroxida-
tion in RL34 cells, ZER (25 lM) dissolved in 5 ll of DMSO was added
to the cell suspension and incubated at 37 C for the diﬀerent periods as
indicated. After rinsing twice with PBS, the cells were treated with
H2O2 (100 lM) and FeSO4 solutions (50 lM), which were incubated for
another 1 h. The reaction was terminated by the addition of 0.4 mM t-
butymydroxytoluene solution. Thiobarbituric acid-reacting substances
(TEARS) level of the collected cells was determined by our previously
reported method [18]. The ﬁnal results are expressed as equivalents of
nmols of malondialdehyde per mg protein, on the basis of a standard
line of TBARS formation using authentic malondialdehyde.
2.9. Statistics
Data were the means of at least three independent experiments.
Speciﬁc diﬀerences among treatments were examined using the Stu-
dent’s t test (two sided) that assumed unequal variance.threne (1 lM) as a positive control for the CYP1A1 induction.3. Results
3.1. ZER is a potential inducer of pi class GST isozyme
As shown in Fig. 1B, the treatment of rat hepatocyte RL34
cells with ZER resulted in a signiﬁcant induction of total GST
activity evaluated using a representative substrate, CDNB. The
GST activity was induced approximately 1.5-fold when cells
were exposed to 25 lMZER for 24 h. To classify the structural
requirement of ZER for GST activity potentiation, the cells
were exposed to a variety of ZER-related compounds at a
concentration of 25 lM for 24 h. Not only the total GST ac-
tivity but also the GSTP1-1 protein were not signiﬁcantly el-
evated in the cells with HUM or 8-OH-HUM (Fig. 1B and C),
suggesting that an a; b-unsaturated carbonyl group as a Mi-
chael reaction acceptor is an essential structural factor for
GST induction by ZER. To examine the GST isozyme re-
sponsible for the increase in the GST activity of the ZER-
treated RL34 cells, an enzyme assay and immunoblot analysis
were carried out using the GST class-speciﬁc antibodies, to
conﬁrm the apparent induction of the GST proteins. The im-
munoblot analysis demonstrated a signiﬁcant increase in the
level of the GSTP1-1 protein level by treatment with ZER
[3.2 0.3-fold of the DMSO control ðn ¼ 3Þ, as determined by
densitometry analysis]. By contrast, untreated RL34 cells ex-
press an undetectable or trace level of the Class alpha and
Class mu proteins whose genes also contain ARE/EpRE se-
quences and these were nearly unchanged by ZER treatment
(data not shown). Insensitivity of their basal and inducible
expression in RL 34 cells may be due to cell speciﬁc eﬀect. The
increase in the GSTP1-1 protein, therefore, might coincide
with a substantial rise in the GST activity. In addition, we
examined the modifying eﬀects of ZER on the GST activities
toward EA, a speciﬁc substrate of Class pi GSTs compared
with the total GST activity using CDNB. The mean ZER-en-
hanced speciﬁc activities of the cytosolic GSTs in RL34 cells
were 67.8 2.1 (CDNB) and 35.3 3.2 (EA) (103) units per
mg protein, respectively. This also supported that half of the
GST induction by ZER was accounted for by the induction ofClass pi GST isozymes. As shown in Fig. 2A and B, the GST-
inducing activity of ZER was conﬁrmed to be in dose- and
time-dependent manners. In addition, ZER did not aﬀect the
CYP1A1 protein level (Fig. 2B), suggesting that ZER might
not activate the pathway dependent on xenobiotic response
element, which is contained in and required for carcinogen-
induced expression of some cytochrome P450 isozymes.
3.2. ZER activates the Nrf2-dependent pathway
Several lines of evidence indicate that a member of the basic
leucine zipper transcription factor family, Nrf2 (NF-E2-related
factor 2), is involved in the activation of gene expression of
phase II enzymes including GSTP1-1 [19]. To determine
whether this transcription factor contributes to the ZER-
stimulated GST induction, we examined the nuclear localiza-
tion of Nrf2 in the ZER-treated RL34 cells. As shown in
Fig. 3A, only cytoplasmic labeling of Nrf2 with no nuclear
staining was observed in the non-stimulated cells (0 h),
whereas an intense nuclear labeling was observed in the ZER-
stimulated cells (6 h). Next, we sought to provide further in-
formation about how the function of Nrf2 is controlled by
ZER. To investigate this point, the fact that MG132-mediated
inhibition of the proteasome is reversible was exploited to
generate a signiﬁcant pool of Nrf2 in RL34 cells [20]. RL34
cells were pretreated with MG132 for 2 h before the protea-
some inhibitor was removed and replaced with media con-
taining CHX and either ZER or vehicle. When cotreated with
CHX and vehicle, a notable reduction in the expression of
Nrf2 was observed after a chase period of 60 min (Fig. 3B),
indicative of proteasomal-mediated degradation [24.5 4.5%
of the 0-h control ðn ¼ 3Þ as determined by densitometry
analysis]. Most importantly, this degradation was clearly in-
hibited by cotreatment with ZER [25 lM; 62.5 6.5% of the 0-
h control ðn ¼ 3Þ]. Overall, these data suggest that Nrf2 is
subject to proteasome-dependent degradation under homeo-
static condition but that the rate of degradation is reduced
signiﬁcantly during the ZER treatment. As shown in Fig. 3C,
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GSTP1, GR, NQO1 and HO-1 mRNA expressions, all of
which are reported to be regulated by the Nrf2-dependent
pathway [21].
3.3. ZER is a biologically active antioxidant
In order to protect against excessive reactive oxygen species
(ROS), aerobic organisms have developed a number of cellular
defenses composed of non-enzymatic and enzymatic compo-Fig. 3. ZER activates the Nrf2-dependent pathway. (A) Induction of
nuclear translocation of Nrf2 by ZER. The RL34 cells treated with
ZER for 0 h or 6 h were ﬁxed in 2% paraformaldehyde and 0.2% picric
acid and immunostained with the anti-Nrf2 antibody. Images of the
cellular immunoﬂuorescence were acquired using a confocal laser
scanning microscope. (B) ZER stabilizes the Nrf2 protein by antago-
nizing its proteasome-dependent degradation. RL34 cells were cultured
with 2.5 lM MG132 for 2 h before CHX was added to a ﬁnal con-
centration of 10 lM. Whole-cell lysates were prepared 0 and 60 min
after the addition of CHX. As for the ZER-treated group, RL34 cells
were cultured with 2.5 lM MG132 for 2 h. Medium was removed and
all monolayer cells were washed with one volume of fresh medium.
Fresh medium containing 10 lM CHX and either ZER (1 25 lM) or
vehicle (0 lM) was added to each dish. Whole-cell lysates were pre-
pared and immunoblotted with the anti-Nrf2 antibody. (C) Eﬀect of
ZER on mRNA expression of the Nrf2-dependent enzyme genes
(GSTP1, OR, NQO1, and HO-1). Total RNA was extracted from
RL34 cells untreated (0 h) or treated with 25 lMZER for the indicated
time periods, and then a RT-PCR analysis was carried out.nents. Some GST isozymes, being able to utilize the major
products of lipid peroxidation including fatty acid hydroper-
oxide and 4-hydroxy-2-nonenal as substrates, play a physio-
logical role in the protection against oxidative stress [22,23].
We preliminarily conﬁrmed that ZER did not show anyFig. 4. ZER acts as a biologically active antioxidant. (A) Enhancement
of intracellular GSH level by ZER. The cells were treated with 25 lM
ZER for diﬀerent time intervals. Intracellular GSH levels were color-
imetrically measured as described in the Materials and Methods sec-
tion. Statistical signiﬁcance was determined by the Student’s t test and
is expressed as: *, versus 0 h, P < 0:05 ðn ¼ 3Þ. (B) Eﬀect of ZER on
mRNA expression of the GSH biosynthesis-related genes (cGCS1 and
-cGCSh). Total RNA was extracted from RL34 cells untreated (0 h) or
treated with 25 lMZER for the indicated time periods, and then a RT-
PCR analysis was carried out. (C) Inhibition of lipid peroxidation by
ZER in RL34 cells. ZER (25 lM) was added to the cell suspension and
incubated at 37 C for the diﬀerent periods as indicated. After rinsing
twice with PBS, the cells were treated with H2O2 (100 lM) and FeSO4
solutions (50 lM), which were incubated for another 1 h. Then,
TBARS levels of the collected cells were determined. Data are means
of three independent experiments. Statistical signiﬁcance was deter-
mined by the Student’s t test and is expressed as: a, versus control,
P < 0:05; b, versus positive control (H2O2+FeSO4), P < 0:05.
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picrylhydrazyl (data not shown). Conversely, treatment with
25 lM ZER led to an initial lowering of cellular GSH (87% of
control at 1 h), which was followed by recovery and then a
dramatic increase over the control (286% of controls at 24 h).
The maximum eﬀect on cGCS subunit mRNA levels was ob-
served after 3 h of the ZER treatment (Fig. 4B), suggesting
that ZER might enhance GSH biosynthesis via the gene ex-
pression of the rate-limiting enzyme. In addtion, the GPx ac-
tivity towards t-butylhydroperoxide was signiﬁcantly increased
about 2.5-fold by the ZER treatment at 25 lM for 24 h (data
not shown), consistent with the result of the GPx gene ex-
pression (Fig. 3C). These results prompted us to examine
whether ZER inhibits lipid peroxidation in RL34 cells. The
H2O2/Fe
2þ-induced oxidative damage was evaluated by the
TBARS level, a well-known biomarker of overall oxidative
damage to cellular constituents such as membrane lipids. The
quantitative data for the levels of TBARS formation in the
H2O2/Fe
2þ-treated cells are shown in Fig. 4C. The increased
level of TBARS caused by the H2O2/Fe
2þ treatment was sig-
niﬁcantly higher than that of the control (1.9 0.7 versus
7.9 1.1 nmol/mg protein, P < 0:05), Pretreatment with ZER
(25 lM) before the H2O2/Fe2þ treatment time-dependentry
inhibited the increase in the TBARS level. Particularly, pre-
treatment for 24 h completely blocked the lipid peroxidation
(4.3 0.4 nmol/mg protein, P < 0:05 versus H2O2/Fe2þ). Thus,
treatment with ZER at the dose required for the induction of
GSH and the GSH metabolizing enzymes actually exhibited an
antioxidant eﬀect in RL34 cells.4. Discussion
Terpenoids, including mono-, sesqui-, di-, and triterpenoids,
are biosynthesized by tandem reactions of the phosphorylated
isoprene unit consisting of ﬁve carbons and are ubiquitously
found in the plant kingdom. Some of these dietary terpenoids
have anticarcinogenic activities in a variety of rodent experi-
ments [24]. For example, d-limonene from the peel oil of or-
ange or lemon has a chemopreventive activity against
mammary, skin, liver, lung and forestomach carcinogenesis.
Clinical trial results also demonstrated that some terpenoids
have the potential of treating cancers without major toxicity
[24]. The further understanding of their biological and physi-
ological mechanisms may lead to the identiﬁcation of more
eﬀective compounds in this category for the prevention and
treatment of targeted cancer types. In the present study, we
demonstrated that ZER, a major sesquiterpene compound of a
tropical ginger Zingiber zerumbet Smith, induces phase II drug
metabolizing enzyme activity potentially via the Nrf2-depen-
dent pathway.
There is substantial and mounting evidence that phase II
drug metabolizing enzymes, e.g., GST, NQO1, epoxide hy-
drolase, hemeoxygenase, and UDP-glucuronosyl-transferase,
play important roles in the detoxiﬁcation of electrophilic tox-
icants and their induction protects against carcinogenesis and
mutagenesis [25], Recently, two transgenic rodent studies
showed that deﬁciency in the GSTP1 expression caused par-
ticular sensitivity towards chemical carcinogenesis in mouse
skin [6] and rat liver [7]. The Class pi rat and human GST
isozymes are highly eﬃcient in the GSH conjugation of car-
cinogenic benz[a]pyrene derivatives [8], widespread environ-mental pollutants in cigarette smoke and automobile exhaust.
In addition, GSTP1 isozyme is more eﬀective for the detoxi-
ﬁcation of electrophilic a; b-unsaturated carbonyl compounds
produced by radical reactions, lipid peroxidation, ionizing
radiation, and the metabolism of drugs than other GSTs [26].
Overexpression of human GSTA2 in human erythroleukemia
K562 cells attenuates lipid peroxidation and confers resistance
to these cells from H2O2 cytotoxicity. Indeed, some GST-in-
ducing agents have been conﬁrmed to be biologically active
antioxidants in vivo [27,28]. Also, topical application of ZER
resulted in a signiﬁcant decrease in the H2O2 level in inﬂamed
mouse skin [4]. Thus, the inducing ability of GST, being able
to catalyze GSH-dependent reduction of hydroperoxide, as
well as the induction of GSH and the GSH metabolizing en-
zymes may mainly participate in its antioxidant eﬀect in RL34
cells.
The topic of the present study is that ZER, having an
electrophilic property, is eﬀective for GST induction, while
the non-electrophilic HUM and 8-OH-HUM are not. This
structure–activity relationship has also been found in some
physiological activities, including suppression of Epstein–Barr
virus activation [1] and inhibition of O2 generation in dif-
ferentiated HL-60 cells [2]. A potential candidate of the trans-
acting factor(s) for the gene expression of GST and other
Phase II enzymes has been recently identiﬁed to be the
transcription factor Nrf2 [21]. It has also been shown by
gene-targeted disruption in mice that Nrf2 is a general reg-
ulator of the Phase II enzyme genes in response to electro-
philes and ROS [19,29]. The general regulatory mechanism
underlying the electrophile counter attack response has been
demonstrated [30], in which electrophilic agents alter the in-
teraction of Nrf2 with its represser protein (Keapl; Kelch-like
ECH-associated protein 1), thereby liberating the Nrf2 ac-
tivity from repression by Keapl, culminating in the induction
of the Phase II enzyme genes and antioxidative stress protein
genes via ARE/EpRE [21]. Keap 1 contains 25 cysteine res-
idues, 4 of which are expected to have highly reactive sulf-
hydryl groups with the inducers [31,32]. As shown in the
present study, the enzyme inducing ability of electrophilic
ZER is more signiﬁcant than those of the other related
compounds. Dinkova-Kostova et al. clearly demonstrated
that the enhancement of phase II enzyme-inducer potency
correlates with rapid reactivity of the agents with model
sulfhydryl compounds [33]. Moreover, the nuclear localiza-
tion of Nrf2 was observed in the ZER-treated RL34 cells
(Fig. 3A). Therefore, the Keapl-Nrf2 complex is one of the
most plausible candidates for the cytoplasmic sensor system
that recognizes inducers including ZER.
Recently, one plausible mechanism that Keapl negatively
regulates Nrf2 function by controlling its subcellular localiza-
tion and accumulation has been proposed. Two research
groups demonstrated that the accumulation of Nrf2 results
from inhibition of its degradation by the 26 S proteasome
[34,35], a feature common to many transcription factors in-
cluding p53, c-Mye, c-Jun, and b-catenin [36]. McMahon et al.
also conﬁrmed that endogenous Nrf2 is subject to 26 S pro-
teasome-dependent degradation and that its rate of degrada-
tion depends upon the redox environment of the cell [19].
Thus, under homeostatic conditions, Keapl interacts with Nrf2
and increases its rate of proteasome-mediated degradation,
leading to a reduction in the cellular level. We demonstrated
here that ZER, possibly by antagonizing the interaction
250 Y. Nakamura et al. / FEBS Letters 572 (2004) 245–250between Nrf2 and Keapl, stabilized Nrf2, leading to its rapid
accumulation within the cell (Fig. 3B).
In conclusion, the results in the present study provide bio-
logical evidence that ZER has a signiﬁcant ability to suppress
oxidative stress possibly through induction of the endogenous
antioxidants such as the phase II xenobiotic metabolizing en-
zymes as well as GSH. Considering the importance of oxida-
tive damage in carcinogenesis, the antioxidant eﬀect of ZER
can be explored as a cancer chemopreventive agent targeted
towards inﬂammation-related carcinogensis such as skin can-
cer and colon cancer.
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